FIGS (FIGS) Could Be 10% Undervalued As Growth Hopes Meet Valuation Doubts
FIGS (FIGS) has attracted fresh attention after recent trading left the share price at $13.06, with performance mixed over different time frames as investors reassess what the current valuation implies.
Over the past year, FIGS has shifted from short bursts of selling pressure to a stronger overall trajectory, with a 14.66% year-to-date share price return paired with a 75.54% total shareholder return. However, the 30-day share price return is down 7.77%, which suggests that recent volatility is occurring against a much stronger longer-term gain in investor confidence.
Compare FIGS' recent swing in sentiment with other consumer-focused opportunities by scanning our curated list of 16 high quality undiscovered gems that are still flying under most investors' radars.
FIGS looks like a solid healthcare apparel business on the surface, yet the recent pullback from its highs puts the spotlight squarely on the tag attached to that quality. Is the current share price still a fair deal for what you are getting?
Most Popular Narrative: 9% Undervalued
On the most followed valuation view, FIGS is assessed at a fair value of $14.39 compared with the latest close at $13.06. This frames the current pullback as a discount rather than a breakdown.
The company, on an absolute basis, is still growing well. Further, it has several growth levers, such as expanding its product range, entering new markets, and leaning into its “TEAMS” offering.
See why 24 investors see FIGS as 9% undervalued.
Result: Fair Value of $14.39 (UNDERVALUED)
Still, FIGS faces real pressure if revenue slows further, or if its premium pricing starts to feel less justifiable for healthcare workers who are watching their budgets closely.
Find out about the key risks to this FIGS narrative.
Another View: FIGS Looks Expensive On Earnings
The SWS DCF model is not the only lens investors are using on FIGS. On a simple P/E basis, the stock trades at 35x earnings compared with 15.6x for the US Luxury group and a fair ratio estimate of 15.5x. That gap points to real valuation risk if sentiment cools.
To see how this earnings multiple stacks up against what the cash flows imply, and whether the current premium leaves any room for error, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed messages on FIGS can make it tempting to lean on headlines, but acting quickly starts with your own homework, not someone else’s conviction. Take a few minutes to weigh both sides of the story by testing the 3 key rewards and 1 important warning sign.
Looking for more FIGS-like investment ideas?
If FIGS has sharpened your focus on valuation and quality, do not stop here. Use the Simply Wall Street Screener to spot other opportunities before the crowd.
- Target resilient compounding potential by scanning a 29 high quality undervalued stocks that combine quality fundamentals with prices that screens flag as below their estimated worth.
- Strengthen your income stream by reviewing 6 dividend fortresses that aim to pair higher yields with balance sheets that can support ongoing payouts.
- Dial down portfolio risk by filtering for 30 resilient stocks with low risk scores that score well on financial health and volatility checks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com